Smiths Medical Announces the ECRI Evaluation of the CADD®-Solis v4 Wireless Ambulatory Infusion System
Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.
- Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.
- View the full release here: https://www.businesswire.com/news/home/20210330005181/en/
CADD-Solis v4 with wireless communications Patient-Controlled Analgesic (PCA) and epidural infusion pump. - (Photo: Business Wire)
The CADD-Solis v4 system is a continuation of Smiths Medicals commitment to advance patient care and help improve patient outcomes through leading-edge technology. - Smiths Medical is committed to patient safety and adoption of smart infusion pumps, said Nathan Walker, Director of Ambulatory Infusion at Smiths Medical.